BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17468292)

  • 21. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
    Calhoun KE; Hansen NM; Turner RR; Giuliano AE
    Am J Surg; 2005 Oct; 190(4):588-91. PubMed ID: 16164927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
    Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
    Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the method of biopsy affect the incidence of sentinel lymph node metastases?
    Newman EL; Kahn A; Diehl KM; Cimmino VM; Kleer CA; Chang AE; Newman LA; Sabel MS
    Breast J; 2006; 12(1):53-7. PubMed ID: 16409587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.
    Cserni G; Bianchi S; Vezzosi V; Arisio R; Bori R; Peterse JL; Sapino A; Drijkoningen M; Kulka J; Eusebi V; Foschini MP; Bellocq JP; Marin C; Thorstenson S; Amendoeira I; Reiner-Concin A; Decker T
    Eur J Cancer; 2007 Jun; 43(9):1407-14. PubMed ID: 17531465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.
    Zavagno G; Belardinelli V; Marconato R; Carcoforo P; Franchini Z; Scalco G; Burelli P; Pietrarota P; Mencarelli R; Marconato G; Nitti D
    Breast; 2007 Apr; 16(2):146-51. PubMed ID: 17046258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
    Hwang RF; Gonzalez-Angulo AM; Yi M; Buchholz TA; Meric-Bernstam F; Kuerer HM; Babiera GV; Tereffe W; Liu DD; Hunt KK
    Cancer; 2007 Aug; 110(4):723-30. PubMed ID: 17587208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
    Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D
    Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions.
    Cserni G; Bianchi S; Vezzosi V; van Diest P; van Deurzen C; Sejben I; Regitnig P; Asslaber M; Foschini MP; Sapino A; Castellano I; Callagy G; Arkoumani E; Kulka J; Wells CA
    Eur J Cancer; 2008 Oct; 44(15):2185-91. PubMed ID: 18691877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer.
    Vargas HI; Vargas MP; Venegas R; Gonzalez KD; Burla M; Mishkin F; Khalkhali I
    Am Surg; 2003 Oct; 69(10):886-90. PubMed ID: 14570368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.
    den Bakker MA; van Weeszenberg A; de Kanter AY; Beverdam FH; Pritchard C; van der Kwast TH; Menke-Pluymers M
    J Clin Pathol; 2002 Dec; 55(12):932-5. PubMed ID: 12461062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease.
    Kumar S; Bramlage M; Jacks LM; Goldberg JI; Patil SM; Giri DD; Van Zee KJ
    Ann Surg Oncol; 2010 Nov; 17(11):2909-19. PubMed ID: 20532987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of sentinel lymph node micrometastases in human breast cancer.
    Cox CE; Kiluk JV; Riker AI; Cox JM; Allred N; Ramos DC; Dupont EL; Vrcel V; Diaz N; Boulware D
    J Am Coll Surg; 2008 Feb; 206(2):261-8. PubMed ID: 18222378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.